Testing effectiveness (Phase 2)Ended earlyNCT03075553
What this trial is testing
Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma
Who this might be right for
Blastic Plasmacytoid Dendritic Cell NeoplasmHepatosplenic T-Cell LymphomaHTLV-1 Infection+14 more
Mayo Clinic 12